T1	Participants 91 131	II type mixed essential cryoglobulinemia
T2	Participants 134 207	Thirty-three patients with II type mixed essential cryoglobulinemia (MEC)
T3	Participants 584 627	patients that responded to combined therapy
T4	Participants 718 770	None of the patients treated with prednisone therapy
T5	Participants 845 916	Four patients (three of combined therapy and one of prednisone therapy)
T6	Participants 1009 1021	Ten patients
T7	Participants 1095 1109	Three patients
T8	Participants 1430 1510	maintenance treatment in the therapy of II type mixed essential cryoglobulinemia
